Go to Client Portal

Clinical Data Requirements Under MDR: A Panel Discussion



NAMSA invites you to join us for an interactive panel discussion on clinical data requirements and challenges under MDR, led by our in-house regulatory experts. Even with the extended MDR transition period for legacy devices, it’s crucial to have a strong clinical data plan for all devices. We’ll begin by addressing common clinical data challenges manufacturers face under MDR, drawing from our experience with clients and notified bodies. Then, we’ll dive into an interactive panel discussion.

Attendees will gain insights into:

  • Clinical Evaluation Report (CER) requirements
  • Defining adequate clinical evidence
  • Evaluating clinical benefits
  • Strategies for Post-Market Follow-Up (PMCF)
  • Expectations of Notified Bodies regarding clinical data

*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com

NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.